Press Release Archive

Date	Title
02/15/12	FDA Approves Gen-Probe's PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies
10/31/11	FDA Approves Gen-Probe's APTIMA® HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
08/22/11	Gen-Probe Receives Canadian Regulatory Clearance for PANTHER® System, Fully Automated and Integrated Molecular Testing Instrument
08/17/11	Gen-Probe Receives Canadian Regulatory Approval for PROGENSA® PCA3 Assay, New Molecular Urine Test to Help Determine Need for Repeat Prostate Biopsies
07/14/11	New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
05/20/11	Gen-Probe Files for US Regulatory Clearance of PANTHER(TM) System, Fully Automated and Integrated Molecular Testing Instrument
04/20/11	FDA Clears First Nucleic Acid Amplification Test to Detect Common Sexually Transmitted Infection Trichomonas Vaginalis
12/08/10	Prodesse ProAdeno(TM)+ Assay Cleared for US Marketing by FDA
11/30/10	Gen-Probe Launches PANTHER(TM) System, Fully Automated and Integrated Molecular Testing Instrument, in Europe
11/29/10	Gen-Probe Files US Regulatory Application for APTIMA(R) HPV Assay, New Molecular Test for Cervical Cancer
11/08/10	Gen-Probe Launches the ELUCIGENETM KRAS.BRAF Kit to Detect Genetic Mutations that Help Determine Colorectal Cancer Treatment
10/04/10	Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
09/21/10	Gen-Probe Files US Regulatory Application for PROGENSA(R) PCA3 Assay, New Molecular Test to Help Determine Need for Repeat Prostate Biopsies
07/26/10	FDA Clears Prodesse's ProFAST(TM)+ Assay to Identify Three Strains of Influenza A, Including 2009 H1N1
06/30/10	Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
04/22/10	PROGENSA® PCA3 Assay Can Help Predict Outcome of Initial Prostate Biopsies, According to Study Presented at Leading Urology Meeting
03/08/10	PROGENSA® PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented at Leading Medical Meeting Confirm
11/24/09	Prodesse's ProParaflu+(TM) Assay Cleared for US Marketing by FDA
11/12/09	Prodesse's ProFlu-ST Assay Receives European CE Mark
10/29/09	FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
08/27/09	Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk
08/17/09	Gen-Probe Begins U.S. Clinical Study of APTIMA(R) Trichomonas Vaginalis Assay on the TIGRIS(R) System
04/29/09	Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
04/29/09	Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
08/13/08	FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
05/28/08	Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
02/21/08	Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
01/08/08	Millipore and Gen-Probe Launch First Real-Time Test for Detecting Microbial Contamination in Biopharmaceutical Applications
05/24/07	FDA Approves Gen-Probe's Automated PROCLEIX(R) TIGRIS(R) System to Test Donated Blood With the PROCLEIX ULTRIO(R) Assay
03/29/07	Promising Data on Molecular Research Test for Prostate Cancer Published in Peer-Reviewed Journal UROLOGY(R)
03/23/07	Results from Multi-Center European Study Highlight New Molecular Test to Improve Prostate Cancer Diagnosis
03/02/07	FDA Approves Gen-Probe's TIGRIS(R) Instrument to Screen Donated Blood for West Nile Virus
11/21/06	New, Highly Specific Gene-Based Test for Prostate Cancer Introduced in Europe
10/18/06	Gen-Probe Receives FDA Clearance to Run Standalone APTIMA(R) Tests for Chlamydia and Gonorrhea on the TIGRIS(R) System
10/16/06	Gen-Probe Broadens Intellectual Property Portfolio Surrounding Automated Nucleic Acid Testing
10/05/06	Gen-Probe Receives FDA Approval for APTIMA(R) HIV-1 RNA Qualitative Assay for Clinical Diagnostic Use
10/04/06	Gen-Probe Receives FDA License for PROCLEIX(R) ULTRIO(R) Assay
09/20/06	Gen-Probe Responds to FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Application
08/22/06	Gen-Probe Receives FDA Clearance to Test Additional Specimen Types for STDs With the APTIMA Combo 2(R) Assay on the TIGRIS(R) System
07/25/06	Gen-Probe Receives Additional FDA Questions on TIGRIS(R) / West Nile Virus Regulatory Applications
04/20/06	Gen-Probe Submits Regulatory Application for Use of PROCLEIX(R) TIGRIS(R) System to Screen Donated Blood for West Nile Virus
03/09/06	Gen-Probe Licenses HPA Technology to Alnylam to Measure Interfering RNAs in Drug Development
12/01/05	Gen-Probe Receives FDA Approval for PROCLEIX(R) West Nile Virus Blood Screening Assay
11/15/05	Gen-Probe Awarded Prestigious National Medal of Technology for Development of Nucleic Acid Tests for Blood Screening
10/14/05	Gen-Probe Provides Update on Regulatory Status of Investigational PROCLEIX(R) ULTRIO(TM) Assay
10/05/05	Gen-Probe Provides Update on Regulatory Applications for Investigational Blood Screening Products
08/31/05	Millipore and Gen-Probe Form Collaboration to Develop Innovative, Rapid Molecular Tests for the Biotech and Pharmaceutical Industries
05/12/05	Gen-Probe Receives Broad U.S. Patent Covering Automated Process for Nucleic Acid Testing
04/19/05	Innovative Urine Test for Highly Specific Prostate Cancer Gene Shows Promise in Preliminary Research
02/02/05	U.S. Biologics License Application Submitted for PROCLEIX(R) West Nile Virus Assay for Blood Screening
01/05/05	Gen-Probe Licenses from Corixa Rights to Develop Molecular Diagnostic Tests for Potential Markers of Genitourinary and Other Cancers
01/03/05	Gen-Probe Licenses Technology From AdnaGen That May Increase Accuracy of Molecular Diagnostic Tests for Cancer
12/27/04	Gen-Probe Receives FDA Marketing Clearance for Standalone APTIMA(R) Test to Detect Chlamydia Trachomatis
02/02/04	Clinical Trials of Procleix(R) Ultrio(TM) Assay Begin on Procleix TIGRIS(R) System
01/06/04	Gen-Probe Receives FDA Approval for Vaginal Self-Collection Kit for the APTIMA COMBO 2(R) Assay
12/29/03	Gen-Probe Receives FDA Approval for STD Testing on the TIGRIS(R) DTS(TM) System, First Fully Automated, Amplified Molecular Diagnostic Testing Instrument
12/11/03	Clinical Trials Begin for Procleix(R) Ultrio(TM) Assay
06/18/03	Gen-Probe Nucleic Acid Test for West Nile Virus Now Available for Use By U.S. Blood Centers Under Investigational New Drug Application
05/19/03	Gen-Probe Initiates Clinical Trial of the TIGRIS(TM) System for Clinical Diagnostic Testing
11/20/02	FDA Approves Expanded Uses for Gen-Probe's HIV-1/HCV Assay
09/05/02	Gen-Probe Announces Results from the Initial Field Evaluation of the TIGRIS Instrument System for Clinical Diagnostic Testing
07/30/02	Gen-Probe and TECAN Expand DTS Platform for Robotic Processing of the APTIMA® Combo 2 Assay for Sexually Transmitted Disease (STD) Testing
02/28/02	Gen-Probe Receives FDA Biologics License Approval in United
05/10/99	Gen-Probe Expands With A New State of the Art Manufacturing Facility